Literature DB >> 4994227

Production of antibody against Pseudomonas aeruginosa and its serological typing.

J Y Homma, H Shionoya, H Yamada, Y Kawabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4994227

Source DB:  PubMed          Journal:  Jpn J Exp Med        ISSN: 0021-5031


× No keyword cloud information.
  9 in total

1.  Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility.

Authors:  N J Legakis; M Aliferopoulou; J Papavassiliou; M Papapetropoulou
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

2.  Type-specific indirect hemagglutinating antibody in patients with Pseudomonas aeruginosa Infection.

Authors:  S Shigeta; Y Yasunaga; M Ogata
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

3.  Role of nonagglutinating antibody in the protracted immunity of vaccinated mice to Pseudomonas aeruginosa infection.

Authors:  M R Moody; R W Kessel; V M Young; P Fiset
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  [Antibody response to somatic and flagellar antigens of Pseudomonas aeruginosa (author's transl)].

Authors:  R Ansorg; W Schmitt; V Schwerk
Journal:  Med Microbiol Immunol       Date:  1978-10-20       Impact factor: 3.402

5.  Epidemiology of Pseudomonas aeruginosa in a general hospital: a four-year study.

Authors:  E T Thomas; L F Jones; E Simão; C Solé-Vernin; J J Farmer
Journal:  J Clin Microbiol       Date:  1975-11       Impact factor: 5.948

6.  Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas.

Authors:  C H Zierdt; R L Williams
Journal:  J Clin Microbiol       Date:  1975-06       Impact factor: 5.948

7.  Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.

Authors:  L E Bryan; A Kureishi; H R Rabin
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

8.  Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.

Authors:  C D Brokopp; R Gomez-Lus; J J Farmer
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

9.  Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  R U Sorensen; R C Stern; S H Polmar
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.